GOP leaders are racing to try to get the bill to the White House by July 4. The multi-trillion-dollar bill would unlock tax ...

A new weight loss treatment that can be taken as either a daily pill or a weekly injection has shown very promising results ...

The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 months ...

What’s interesting is that this drug is NOT approved by the Food and Drug Administration as a treatment for weight loss. It is approved for the treatment of Type 2 diabetes in adults.

Semaglutide isn’t usually covered by insurance when it’s used as a weight loss drug. (If you have type 2 diabetes, you have a much higher chance of getting your insurance provider to foot the ...

Novo Nordisk produces the GLP-1 weight loss agonists Wegovy, Ozempic, and other medications that contain semaglutide, which has been shown to lower blood sugar and support weight loss.

“Ozempic is approved in Malaysia specifically for managing type 2 diabetes. However, semaglutide’s weight loss benefits have led some to seek it off-label for obesity treatment,” she said.

Originally developed to treat type 2 diabetes, GLP-1 receptor agonists – semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) – are now increasingly being used for aesthetic weight loss ...

Ozempic is also becoming increasingly popular for weight loss, which is an off-label use. However, in 2021, the FDA approved semaglutide, the same active drug in Ozempic, under the brand name ...

Ro, formerly known as Roman, is a telehealth service offering OTC and prescription treatments for sexual health, weight loss, and more. Read our full review here.

European regulators have confirmed that Novo Nordisk’s semaglutide increases the risk of a rare eye condition that can cause vision loss. The conclusion from the European Medicines Agency (EMA) ...